Gabapentin is a prescription anticonvulsant used for postherpetic neuralgia and as adjunctive treatment for partial-onset seizures. Prescribed use follows a clinician's directions, misuse departs from those directions, and addiction involves impaired control and continued use despite harm.
Gabapentin can cause physical dependence during appropriate treatment, and withdrawal can follow an abrupt stop or substantial dose reduction. Dependence is physiologic adaptation; addiction is a behavioral and clinical pattern; one does not prove the other.
What is gabapentin?
Clinical perspective
Gabapentin gets repurposed constantly — it started for seizures, and it's now used for nerve pain, anxiety, and sometimes to ease alcohol withdrawal symptoms. It's not without misuse potential of its own, especially for someone with an opioid use history, so it still requires careful monitoring even though it's not a controlled substance everywhere.
Gabapentin is a gabapentinoid medication that changes calcium-channel signaling without acting as an opioid, benzodiazepine, or direct GABA-receptor agonist. The FDA-approved Neurontin label lists postherpetic neuralgia in adults and adjunctive treatment of partial-onset seizures in patients age 3 years and older as its indications.
Clinicians also prescribe gabapentin off label, but an off-label prescription is not misuse when a licensed clinician directs it for an individual patient. Neurontin, Gralise, and Horizant contain gabapentin or a gabapentin prodrug, yet their formulations, release patterns, approved uses, and dosing instructions are not interchangeable.
How does gabapentin work?
Gabapentin binds with high affinity to the alpha-2-delta subunit of voltage-activated calcium channels, but its precise analgesic and antiseizure mechanisms remain unknown. It is structurally related to gamma-aminobutyric acid, does not change GABA binding, uptake, or degradation, and does not bind opioid or benzodiazepine receptors.
Gabapentin and pregabalin are related gabapentinoids, but they have different absorption, dosing, approved indications, and federal control status. A patient should not substitute one for the other or convert a dose without prescribing guidance.
Is gabapentin a controlled substance?
Gabapentin is a prescription drug but is not a controlled substance under the federal Controlled Substances Act. Federal status does not mean the medicine is risk free: the FDA label documents postmarketing misuse and abuse, the DEA documents diversion and forensic encounters, and some states impose additional controls or prescription-monitoring requirements.
DEA reported approximately 73.3 million U.S. gabapentin prescriptions in 2025, up from 29.6 million in 2010. Those figures measure dispensed prescriptions, not misuse, addiction, treatment need, or overdose.
How do prescribed use, misuse, dependence, and addiction differ?
Prescribed use follows the treatment plan, misuse changes the therapeutic use or uses another person's medicine, and addiction adds impaired control and continued use despite harm. Within the broader topic of prescription drug misuse, taking extra doses, escalating without approval, using someone else's gabapentin, or combining it to change another drug's effects are misuse patterns.
- Tolerance: a particular effect becomes weaker with repeated exposure, although tolerance does not develop uniformly and does not alone establish addiction.
- Physical dependence: repeated exposure produces physiologic adaptation and withdrawal after an abrupt stop or substantial reduction.
- Substance use disorder: impaired control, hazardous use, functional disruption, or continued use despite consequences causes clinically significant impairment or distress.
The FDA label notes self-directed dose escalation and drug-seeking behavior as warning signs, but no single behavior proves a diagnosis. A clinician considers the prescription, intent, dose pattern, co-exposures, function, consequences, and unsuccessful efforts to reduce use.
What are the signs of gabapentin misuse or addiction?
Gabapentin misuse or addiction can appear as unauthorized dose escalation, compulsive use, hazardous combinations, and continued use despite harm. The relevant pattern may involve the medication alone, an opioid or sedative combination, or repeated use intended to intensify intoxication.
- Medication behaviors: taking doses early, using more than directed, obtaining overlapping supplies, or using a formulation prescribed to someone else.
- Impaired control: craving, repeated unsuccessful attempts to reduce use, or spending substantial time obtaining, using, or recovering from the drug.
- Functional effects: missed responsibilities, unsafe driving, falls, interpersonal conflict, or continued use despite cognitive or physical problems.
- High-risk combinations: using gabapentin with opioids, benzodiazepines, alcohol, sleep medicines, or other sedating substances outside a coordinated plan.
Drowsiness, dizziness, or withdrawal after a late dose can occur without addiction. Assessment must distinguish an adverse effect, undertreated pain, physical dependence, intoxication, withdrawal, and compulsive use because each finding calls for a different response.
What side effects and serious reactions can gabapentin cause?
Gabapentin commonly causes somnolence, dizziness, and impaired coordination, and it can also cause serious hypersensitivity, mood, seizure, and breathing reactions. Sedation can impair driving, ataxia can increase fall risk, and reduced kidney function can increase exposure because the drug is eliminated unchanged through the kidneys.
Difficulty breathing, swelling of the lips or throat, widespread rash with fever, new suicidal thoughts, or a seizure requires urgent clinical evaluation. The FDA label warns about anaphylaxis and angioedema, DRESS or multiorgan hypersensitivity, suicidal thoughts or behavior associated with antiepileptic drugs, and respiratory depression.
Why are gabapentin and opioids a dangerous combination?
A gabapentin-opioid interaction can compound sedation, suppress breathing, and increase the risk of a fatal mixed-drug overdose. The FDA identifies opioid use, another central nervous system depressant, underlying respiratory impairment, and older age as respiratory risk factors for gabapentinoids.
CDC reviewed 58,362 overdose deaths with documented toxicology in 23 states and the District of Columbia during 2019-2020: gabapentin was detected in 5,687 deaths, was considered involved in 2,975 of those deaths, and appeared with an opioid in 85% to 90% of gabapentin-positive deaths. Detection does not prove causation, involvement reflects death-investigation findings, and these jurisdictions and years do not represent a current national rate.
Someone using gabapentin alongside an opioid should receive medication review, overdose education, and monitoring proportionate to respiratory risk. Alcohol, benzodiazepines, antihistamines, sleep medicines, and other sedatives can add impairment even when no opioid is present.
What happens during a gabapentin overdose?
Gabapentin overdose can cause double vision, tremor, slurred speech, drowsiness, altered mental status, dizziness, lethargy, and diarrhea. The FDA label also reports fatal respiratory depression after gabapentin overdose alone and in combination with other central nervous system depressants.
Call 911 when a person cannot be awakened, breathes slowly or irregularly, develops blue or gray lips, has a seizure, or becomes severely confused. Give naloxone when opioid exposure is possible because it can reverse the opioid component; naloxone does not reverse gabapentin, and breathing support and emergency care remain necessary.
There is no specific gabapentin antidote. Poison Control can guide an exposure at 1-800-222-1222, emergency clinicians provide supportive care, and hemodialysis can remove gabapentin in selected circumstances.
What does gabapentin withdrawal involve?
Gabapentin withdrawal can involve neurologic, psychiatric, autonomic, and gastrointestinal symptoms after abrupt discontinuation or a substantial dose reduction. The FDA label reports that symptoms usually began within 48 hours and included seizures, agitation, confusion, anxiety, insomnia, nausea, pain, sweating, tremor, headache, dizziness, and malaise.
The reported 48-hour onset is not a guaranteed timeline, and the label does not establish one universal taper schedule for every indication or patient. Dose, duration, kidney function, seizure history, co-exposures, prior withdrawal, and the condition being treated can change onset, severity, and the appropriate level of care.
A patient should not stop gabapentin abruptly without speaking with the prescriber, especially when it treats seizures or when withdrawal has occurred before. Seizure, psychosis, severe confusion, suicidal behavior, or unstable vital signs requires emergency assessment rather than an improvised home taper.
How is gabapentin addiction treated?
Gabapentin addiction treatment first stabilizes overdose or withdrawal risk, then addresses compulsive use, co-occurring conditions, and continuing recovery needs. A prescriber manages medication reduction when indicated; an addiction clinician evaluates use-disorder severity; behavioral care addresses craving, triggers, impaired control, and consequences.
No medication is specifically FDA approved to treat gabapentin use disorder. A prescription drug treatment program may combine medical coordination, individual and group therapy, family support, relapse-prevention planning, and continuing care after acute medical stability is established.
Treatment setting follows risk rather than the drug name alone. Severe withdrawal, seizure risk, respiratory instability, or dangerous polysubstance exposure can require hospital or medically managed care, while a stable patient may receive outpatient rehabilitation with coordinated prescribing.
How do co-occurring conditions affect gabapentin recovery?
Chronic pain, epilepsy, anxiety, insomnia, depression, and another substance use disorder can complicate gabapentin reduction and recovery. Removing the medication without treating the original symptoms can destabilize care, while treating only the original condition can miss compulsive use and overdose risk.
Dual diagnosis care can coordinate psychiatric treatment, pain or seizure care, substance-use therapy, medication review, and recovery support. The plan should preserve legitimate treatment, reduce hazardous exposure, and respond to the person's actual diagnosis rather than assuming every dependent patient is addicted.
What are common questions about gabapentin?
Common gabapentin questions focus on control status, dependence, withdrawal, testing, and emergency response. The prescription, dose pattern, kidney function, co-exposures, and symptoms determine the clinically relevant answer.
Is gabapentin an opioid or narcotic?
No. Gabapentin is a gabapentinoid anticonvulsant, does not bind opioid receptors, and is not federally classified as a narcotic or controlled substance.
Can prescribed gabapentin cause physical dependence?
Yes. Physical dependence and withdrawal can occur during prescribed use, but neither condition alone establishes addiction.
Does a larger gabapentin dose produce proportionally greater exposure?
No. FDA pharmacokinetic data show that oral bioavailability decreases as the total daily dose rises, so exposure does not increase in direct proportion to dose.
Does naloxone reverse gabapentin overdose?
No. Naloxone reverses opioids, not gabapentin; give it when opioid exposure is possible and continue emergency breathing support.